Lutetium-177 Chloride Radiochemical

Lutetium-177 (Lu-177) is a radioisotope used in targeted radionuclide therapy to treat certain neuroendocrine tumors and prostate cancer. Lu-177 can be combined with tumor-targeting vectors that guide the isotope to diseased cells within the body and attaches to them. 

As the Lu-177 undergoes radioactive decay, it delivers a large dose of beta particles that can destroy the diseased cells. Lu-177-based radiotherapies have achieved success in a variety of types of cancer.